Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Ionis Pharmaceuticals (IONS)

Ionis Pharmaceuticals (IONS)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,838,495
  • Shares Outstanding, K 140,500
  • Annual Sales, $ 599,670 K
  • Annual Income, $ 273,740 K
  • 60-Month Beta 1.95
  • Price/Sales 13.25
  • Price/Cash Flow 17.67
  • Price/Book 5.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate -0.29
  • Number of Estimates 8
  • High Estimate -0.15
  • Low Estimate -0.50
  • Prior Year -0.03
  • Growth Rate Est. (year over year) -866.67%

Price Performance

See More
Period Period Low Period High Performance
1-Month
55.26 +0.96%
on 10/18/19
64.27 -13.19%
on 10/15/19
-7.32 (-11.60%)
since 09/18/19
3-Month
55.26 +0.96%
on 10/18/19
73.09 -23.67%
on 08/21/19
-14.65 (-20.80%)
since 07/18/19
52-Week
44.60 +25.09%
on 10/22/18
86.58 -35.56%
on 04/08/19
+9.44 (+20.37%)
since 10/18/18

Most Recent Stories

More News
Ionis Pharmaceut Set to Possibly Rebound After Yesterday's Selloff of 6.32%

Ionis Pharmaceut (NASDAQ:IONS) traded in a range yesterday that spanned from a low of $56.46 to a high of $60.04. Yesterday, the shares fell 6.3%, which took the trading range below the 3-day low of...

IONS : 55.79 (-1.33%)
Shares of Natera Inc Rank the Highest in Terms of Relative Performance in the Biotechnology Industry (NTRA , IONS , ALXN , CARA , CTMX )

We looked at the Biotechnology industry and measured relative performance to find the top stocks. Relative outperformance is a bullish sign of underlying fundamental and technical strength. We look at...

ALXN : 98.41 (-1.58%)
IONS : 55.79 (-1.33%)
NTRA : 38.51 (+1.37%)
Ionis' leadership in RNA-targeted therapeutics recognized at the Oligonucleotide Therapeutics Society annual meeting

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that its scientists will present data highlighting advances in the company's antisense technology that...

IONS : 55.79 (-1.33%)
Biotech Stock Roundup: GILD's Descovy Label Expansion Gets FDA Nod & Other Updates

Key highlights of the past week include label expansion of drugs, licensing deals and more.

PFE : 36.46 (unch)
VSTM : 1.13 (unch)
ACAD : 39.95 (-0.08%)
GILD : 64.91 (-0.49%)
IONS : 55.79 (-1.33%)
AKCA : 18.08 (-4.49%)
Ionis' Factor XI anti-thrombotic medicine advances with Bayer following positive clinical results

https://mma.prnewswire.com/media/882077/Ionis_Logo.jpg

IONS : 55.79 (-1.33%)
Watch for Ionis Pharmaceut to Potentially Pullback After Gaining 3.79% Yesterday

Ionis Pharmaceut (NASDAQ:IONS) traded in a range yesterday that spanned from a low of $58.87 to a high of $61.12. Yesterday, the shares gained 3.8%, which took the trading range above the 3-day high...

IONS : 55.79 (-1.33%)
Akcea and Pfizer Inc. Announce Licensing Agreement for investigative antisense therapy AKCEA-ANGPTL3-L(Rx)

Akcea Therapeutics, Inc. (NASDAQ: AKCA), a majority-owned affiliate of Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) and Pfizer Inc. (NYSE:PFE), today announced that the companies have entered into a worldwide...

AKCA : 18.08 (-4.49%)
IONS : 55.79 (-1.33%)
PFE : 36.46 (unch)
Landmark NURTURE Study of Infants with Spinal Muscular Atrophy (SMA) Treated Pre-Symptomatically with SPINRAZA(R) (nusinersen) Published in Neuromuscular Disorders

-- Motor milestones achieved included 100 percent of participants sitting without support and 88 percent walking independently; unprecedented outcomes in comparison to the natural history of the disease...

BIIB : 220.06 (-2.46%)
IONS : 55.79 (-1.33%)
Achillion's Danicopan Gets Breakthrough Therapy Tag for PHN

Achillion's (ACHN) oral factor D inhibitor, danicopan, receives Breakthrough Therapy designation from the FDA as a treatment option for PNH. Shares up.

NVS : 86.88 (-0.40%)
ALXN : 98.41 (-1.58%)
ACHN : 6.09 (-1.77%)
IONS : 55.79 (-1.33%)
Ionis to receive the CLSA's 2019 Pantheon DiNA(TM) Award for Company of the Year

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS), the leader in RNA-targeted therapeutics, announced today that the California Life Sciences Association (CLSA), the trade association representing California's...

IONS : 55.79 (-1.33%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade IONS with:

Business Summary

Ionis Pharmaceuticals, Inc. is a RNA-targeted drug discovery and development company which focuses on developing drugs for severe and rare diseases. Ionis Pharmaceuticals, Inc., formerly known as Isis Pharmaceuticals, Inc., is headquartered in Carlsbad, California.

See More

Key Turning Points

2nd Resistance Point 57.18
1st Resistance Point 56.49
Last Price 55.79
1st Support Level 55.18
2nd Support Level 54.56

See More

52-Week High 86.58
Fibonacci 61.8% 70.54
Fibonacci 50% 65.59
Fibonacci 38.2% 60.64
Last Price 55.79
52-Week Low 44.60

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar